TTBB CAS 124750-51-2 Purity >96.0% (HPLC) Irbesartan Intermediate Factory
Ruifu Chemical Supply Irbesartan Intermediates:
Irbesartan CAS 138402-11-6
Cyano-Irbesartan CAS 138401-24-8
Trityl Irbesartan CAS 138402-10-5
TTBB CAS 124750-51-2
Irbesartan Side Chain Hydrochloride CAS 151257-01-1
Jina la Kemikali | 5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole |
Visawe | TTBB;BBTT;5-[4'-Bromomethyl-(1,1'-Biphenyl)-2-yl]-1-Triphenylmethyltetrazole;N-(Triphenylmethyl) -5-(4'-Bromomethylbiphenyl-2-yl-)tetrazole;Uchafu wa Olmesartan 12;Uchafu wa Losartan Bromo N1-Trityl |
Nambari ya CAS | 124750-51-2 |
Nambari ya CAT | RF-PI1878 |
Hali ya Hisa | Katika Hisa, Uwezo wa Uzalishaji 150MT/Mwaka |
Mfumo wa Masi | C33H25BrN4 |
Uzito wa Masi | 557.48 |
Kiwango cha kuyeyuka | 152.0~155.0℃ |
Msongamano | 1.28±0.10 g/cm3 |
Chapa | Ruifu Chemical |
Kipengee | Vipimo |
Mwonekano | Poda Nyeupe hadi Karibu Nyeupe |
Njia ya Usafi / Uchambuzi | >96.0% (HPLC) |
Kupoteza kwa Kukausha | <0.50% |
Uchafu A | <2.00% (HPLC) 5-(4-Methyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole |
Uchafu B | <2.00% 5-(4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole |
Spectrum ya Infrared | Inalingana na Muundo |
Kiwango cha Mtihani | Kiwango cha Biashara |
Matumizi | Kati ya Irbesartan (CAS: 138402-11-6);Uchafu wa Olmesartan Medoxomil |
Kifurushi: Chupa, begi ya karatasi ya Alumini, Ngoma ya 25kg/Cardboard, au kulingana na mahitaji ya mteja
Hali ya Uhifadhi:Hifadhi kwenye vyombo vilivyofungwa mahali pa baridi na kavu;Kinga kutoka kwa mwanga na unyevu
5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazole (TTBB) (CAS: 124750-51-2) ni ya kati ya Irbesartan (CAS: 138402-11 -6).Irbesartan hutumiwa kutibu shinikizo la damu, pamoja na nephropathy ya kisukari na kiwango cha juu cha serum creatinine na proteinuria (zaidi ya 300 mg / siku) kwa wagonjwa walio na ugonjwa wa kisukari cha aina ya 2 na shinikizo la damu.Irbesartan pia hutumiwa kama wakala wa mstari wa pili katika matibabu ya msongamano.Irbesartan ni mpinzani wa kipokezi cha angiotensin II kinachotumiwa hasa kwa matibabu ya shinikizo la damu.Ilianzishwa na Utafiti wa Sanofi (sasa ni sehemu ya Sanofi-Aventis).Inauzwa kwa pamoja na Sanofi-Aventis na Bristol-Myers Squibb chini ya majina ya biashara ya Aprovel, Karvea, na Avapro.